Ray JG, Rosendaal FR. The role of dyslipidemia and statins in venous thromboembolism.
CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE 2001;
2:165-170. [PMID:
11806791 PMCID:
PMC59643 DOI:
10.1186/cvm-2-4-165]
[Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the prevention and treatment of VTE and suggest future directions for research.
Collapse